Literature DB >> 17180269

Laparoscopic Roux-en-Y gastric bypass versus laparoscopic vertical banded gastroplasty: results of a 2-year follow-up study.

M Goergen1, K Arapis, A Limgba, M Schiltz, V Lens, J S Azagra.   

Abstract

BACKGROUND: The world's epidemic of obesity is responsible for the development of bariatric surgery in recent decades. The number of gastrointestinal surgeries performed annually for severe obesity (BMI > 40 kg/m2) in the United States has increased from about 16,000 in the early 1990s to about 103,000 in 2003. The surgical techniques can be classified as restrictive, malabsorptive, or mixed procedures. This article presents the results for 2 years of bariatric surgery in the authors' minimally invasive center and analyzes the results of the most used surgical techniques with regard to eating habits.
METHODS: Between January 2002 and January 2004, the authors attempted operations for morbid obesity in 110 consecutive patients adequately selected by a multidisciplinary obesity unit. This represented 43% of all consultations for morbidly obese patients. The patients were classified as sweet eaters or non-sweet eaters. All sweet eaters underwent gastric bypass. The procedures included 70 Roux-en-Y gastric bypasses, 39 Mason's vertical banded gastroplasties, and 1 combination of vertical gastroplasty with an antireflux procedure. Revision procedures were excluded.
RESULTS: The mean age of the patients was 41.36 years (range, 23-67 years), and 72.3% were female. The mean preoperative body mass index was 44.78 kg/m2 (range, 34.75-70.16 kg/m2). The mean operating time was longer for gastric bypass than for the Mason procedure. Three patients required conversion to an open procedure (2.7%). The two operative techniques had the same efficacy in weight reduction. Early complications developed in 11 patients (10%), and late complications occurred in 9 patients (8.1%). The postoperative length of hospital stay averaged 4.4 days (range, 1-47 days; median, 4 days), and was longer in the gastric bypass group. The mortality rate was zero. Data were available 2 years after surgery for 101 of the 110 patients (91%). Most comorbid conditions resolved by 1 year after surgery regardless of the type of operation used.
CONCLUSION: With zero mortality and low morbidity, bariatric surgery performed for adequately selected patients is the most effective therapeutic intervention for weight loss and subsequent amelioration or resolution of comorbidities. The patient's eating habits before surgery play an important role in the choice of the operative technique used.

Entities:  

Mesh:

Year:  2006        PMID: 17180269     DOI: 10.1007/s00464-006-9081-z

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   3.453


  19 in total

1.  Laparoscopic gastric bypass versus laparoscopic adjustable gastric banding: a comparative study of 1,200 cases.

Authors:  Laurent Biertho; Rudolf Steffen; Thomas Ricklin; Fritz F Horber; Alfons Pomp; William B Inabnet; Daniel Herron; Michel Gagner
Journal:  J Am Coll Surg       Date:  2003-10       Impact factor: 6.113

2.  Overweight and obesity worldwide now estimated to involve 1.7 billion people.

Authors:  Mervyn Deitel
Journal:  Obes Surg       Date:  2003-06       Impact factor: 4.129

3.  Laparoscopic gastric bypass is superior to laparoscopic gastric banding for treatment of morbid obesity.

Authors:  Markus Weber; Markus K Müller; Tanja Bucher; Stefan Wildi; Daniel Dindo; Fritz Horber; Rennward Hauser; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

4.  Bariatric surgery for morbid obesity.

Authors:  M J Monteforte; C M Turkelson
Journal:  Obes Surg       Date:  2000-10       Impact factor: 4.129

5.  Meta-analysis: surgical treatment of obesity.

Authors:  Melinda A Maggard; Lisa R Shugarman; Marika Suttorp; Margaret Maglione; Harvey J Sugerman; Harvey J Sugarman; Edward H Livingston; Ninh T Nguyen; Zhaoping Li; Walter A Mojica; Lara Hilton; Shannon Rhodes; Sally C Morton; Paul G Shekelle
Journal:  Ann Intern Med       Date:  2005-04-05       Impact factor: 25.391

6.  Laparoscopic Roux-en-Y gastric bypass for morbid obesity: technique and preliminary results of our first 400 patients.

Authors:  K D Higa; K B Boone; T Ho; O G Davies
Journal:  Arch Surg       Date:  2000-09

Review 7.  Gastric bypass.

Authors:  R E Brolin
Journal:  Surg Clin North Am       Date:  2001-10       Impact factor: 2.741

8.  Gastric bypass versus gastroplasty. A prospective study of differences in two surgical procedures for morbid obesity.

Authors:  I Näslund
Journal:  Acta Chir Scand Suppl       Date:  1987

9.  Years of life lost due to obesity.

Authors:  Kevin R Fontaine; David T Redden; Chenxi Wang; Andrew O Westfall; David B Allison
Journal:  JAMA       Date:  2003-01-08       Impact factor: 56.272

10.  Weight loss and dietary intake after vertical banded gastroplasty and Roux-en-Y gastric bypass.

Authors:  R E Brolin; L B Robertson; H A Kenler; R P Cody
Journal:  Ann Surg       Date:  1994-12       Impact factor: 12.969

View more
  9 in total

1.  Improved heart rate recovery after marked weight loss induced by gastric bypass surgery: two-year follow up in the Utah Obesity Study.

Authors:  Stephen L Wasmund; Theophilus Owan; Frank G Yanowitz; Ted D Adams; Steven C Hunt; Mohamed H Hamdan; Sheldon E Litwin
Journal:  Heart Rhythm       Date:  2010-10-20       Impact factor: 6.343

2.  Reversible gastric restriction implant: safety and efficacy in a canine model.

Authors:  Xiaomei Guo; Hai Zheng; Samer G Mattar; Xiao Lu; George Sandusky; Jose A Navia; Ghassan Kassab
Journal:  Obes Surg       Date:  2011-09       Impact factor: 4.129

3.  SAGES guideline for clinical application of laparoscopic bariatric surgery.

Authors: 
Journal:  Surg Endosc       Date:  2008-10       Impact factor: 4.584

4.  15-year follow-up of vertical banded gastroplasty: comparison with other restrictive procedures.

Authors:  Yu-Hung Lin; Wei-Jei Lee; Kong-Han Ser; Shu-Chun Chen; Jung-Chien Chen
Journal:  Surg Endosc       Date:  2015-06-05       Impact factor: 4.584

Review 5.  Gut microbiome: Linking together obesity, bariatric surgery and associated clinical outcomes under a single focus.

Authors:  Konstantinos Georgiou; Nikolay A Belev; Tilemachos Koutouratsas; Hector Katifelis; Maria Gazouli
Journal:  World J Gastrointest Pathophysiol       Date:  2022-05-22

Review 6.  Clinical application of laparoscopic bariatric surgery: an evidence-based review.

Authors:  Timothy M Farrell; Stephen P Haggerty; D Wayne Overby; Geoffrey P Kohn; William S Richardson; Robert D Fanelli
Journal:  Surg Endosc       Date:  2009-01-06       Impact factor: 4.584

Review 7.  Long-term effects of bariatric surgery on type II diabetes, hypertension and hyperlipidemia: a meta-analysis and meta-regression study with 5-year follow-up.

Authors:  Cristian Ricci; Maddalena Gaeta; Emanuele Rausa; Emanuele Asti; Francesco Bandera; Luigi Bonavina
Journal:  Obes Surg       Date:  2015-03       Impact factor: 4.129

8.  Laparoscopic Magenstrasse and Mill gastroplasty. First results of a prospective study.

Authors:  Arnaud De Roover; Laurent Kohnen; Jenny Deflines; Barbara Lembo; Vinciane Goessens; Nicolas Paquot; Severine Lauwick; Abdourhamane Kaba; Jean Joris; Michel Meurisse
Journal:  Obes Surg       Date:  2015-02       Impact factor: 4.129

9.  Rejecting the demise of vertical-banded gastroplasty: a long-term single-institute experience.

Authors:  Mohamed Bekheit; Khaled Katri; Wael Nabil Abdel Salam; Tarek Ezzat; El Said El Kayal
Journal:  Obes Surg       Date:  2013-10       Impact factor: 4.129

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.